Definitive Contract W15QKN10C0030

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business focused on medical research and development. The $150,000.00 Firm Fixed Price contract is for research under the SBIR program. As a prime contractor, Critical Innovations has previously received over $10 million in SBIR contracts from various military agencies for the development of medical products including devices for wound...

This is a $150,000.00 Firm Fixed Price contract awarded by the Department of the Army to Critical Innovations LLC, a Limited Liability Company, under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I SBIR effort on the topic of "DIVER PERFORMANCE MONITORING SYSTEM". It is designated as a Total Small Business set-aside. Critical Innovations is an ISO certified, Defense Contract Audit Agency (DCAA) compliant medical research and development company that...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...

��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������...

This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Targagenix, Inc. for R&D on a nanoemulsion formulation and IND-enabling studies of a novel cancer stem cell cytotoxic agent. The definitive, firm-fixed-price contract has a ceiling value of $2,284,577.00 and a period of performance ending on October 15, 2018. As an SBIR Phase I award, this contract supports early-stage research and development...

This is a $150,000.00 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business limited liability company, under the Small Business Innovation Research (SBIR) program. The contract is for Phase I research and development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control". Critical Innovations is an ISO certified and DCAA compliant medical research and development company that has been awarded over $10...

This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...

The U.S. National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Celldex Therapeutics, Inc. in the amount of $199,398.00 on September 20, 2012. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a firm fixed price pricing type. The contract has an ultimate completion date of August 23, 2013. This SBIR Phase I award supports basic research and development activities at Celldex Therapeutics, a for-profit small...

This is a firm fixed-price Definitive Contract awarded by the Department of the Army Medical Command to Critical Innovations LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract, valued at $1,100,000.00, is for the development of a "Nanostasis Intravenous Agent for Traumatic Hemorrhage Control" as part of a Phase II SBIR effort. Critical Innovations LLC is an ISO certified, DCAA compliant medical research and development company that has been...